Fund profile
Tickers
XPH
Fund manager
Total assets
$236.50 mm
Liabilities
$13.91 mm
Net assets
$222.58 mm
Number of holdings
38.00
XPH stock data
38 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
OGN Organon & Co. | 11.91 mm | 825.85 k shares | 5.35 | Common equity | Long | USA |
State Street Navigator Securities Lending Government Money Market Portfolio | 11.76 mm | 11.76 mm shares | 5.29 | Short-term investment vehicle | Long | USA |
CTLT Catalent Inc. | 11.00 mm | 244.78 k shares | 4.94 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 10.81 mm | 150.95 k shares | 4.86 | Common equity | Long | USA |
ELAN Elanco Animal Health Inc | 10.59 mm | 711.01 k shares | 4.76 | Common equity | Long | USA |
AXSM Axsome Therapeutics Inc | 10.32 mm | 129.68 k shares | 4.64 | Common equity | Long | USA |
VTRS Viatris Inc | 10.03 mm | 925.83 k shares | 4.50 | Common equity | Long | USA |
Perrigo Co PLC
|
9.88 mm | 306.94 k shares | 4.44 | Common equity | Long | Ireland |
ZTS Zoetis Inc - Ordinary Shares | 9.73 mm | 49.30 k shares | 4.37 | Common equity | Long | USA |
CBAY Cymabay Therapeutics Inc | 9.67 mm | 409.42 k shares | 4.34 | Common equity | Long | USA |
MRK Merck & Co Inc | 9.56 mm | 87.72 k shares | 4.30 | Common equity | Long | USA |
Jazz Pharmaceuticals PLC
|
9.30 mm | 75.58 k shares | 4.18 | Common equity | Long | Ireland |
BMY Bristol-Myers Squibb Co. | 9.28 mm | 180.90 k shares | 4.17 | Common equity | Long | USA |
JNJ Johnson & Johnson | 9.24 mm | 58.94 k shares | 4.15 | Common equity | Long | USA |
PFE Pfizer Inc. | 9.10 mm | 316.22 k shares | 4.09 | Common equity | Long | USA |
Royalty Pharma PLC
|
8.95 mm | 318.55 k shares | 4.02 | Common equity | Long | UK |
LLY Lilly(Eli) & Co | 8.87 mm | 15.22 k shares | 3.98 | Common equity | Long | USA |
CORT Corcept Therapeutics Inc | 6.07 mm | 186.82 k shares | 2.73 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals Inc | 5.99 mm | 407.00 k shares | 2.69 | Common equity | Long | USA |
RVNC Revance Therapeutics Inc | 5.58 mm | 635.01 k shares | 2.51 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings Inc | 5.29 mm | 163.85 k shares | 2.38 | Common equity | Long | USA |
AMPH Amphastar Pharmaceuticals Inc | 4.99 mm | 80.67 k shares | 2.24 | Common equity | Long | USA |
PCRX Pacira BioSciences Inc | 4.66 mm | 138.14 k shares | 2.09 | Common equity | Long | USA |
SAVA Cassava Sciences Inc | 4.23 mm | 187.77 k shares | 1.90 | Common equity | Long | USA |
PBH Prestige Consumer Healthcare Inc | 3.74 mm | 61.06 k shares | 1.68 | Common equity | Long | USA |
SUPN Supernus Pharmaceuticals Inc | 3.20 mm | 110.64 k shares | 1.44 | Common equity | Long | USA |
ARVN Arvinas Inc | 2.77 mm | 67.34 k shares | 1.25 | Common equity | Long | USA |
PLRX Pliant Therapeutics Inc | 2.67 mm | 147.60 k shares | 1.20 | Common equity | Long | USA |
ANIP ANI Pharmaceuticals Inc | 2.59 mm | 46.97 k shares | 1.16 | Common equity | Long | USA |
INVA Innoviva Inc | 2.40 mm | 149.77 k shares | 1.08 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals Inc | 2.28 mm | 112.47 k shares | 1.02 | Common equity | Long | USA |
COLL Collegium Pharmaceutical Inc | 1.93 mm | 62.54 k shares | 0.86 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | 1.77 mm | 24.83 k shares | 0.80 | Common equity | Long | USA |
AMRX Amneal Pharmaceuticals Inc - Ordinary Shares | 1.59 mm | 261.99 k shares | 0.71 | Common equity | Long | USA |
EOLS Evolus Inc | 1.15 mm | 108.78 k shares | 0.51 | Common equity | Long | USA |
Theravance Biopharma Inc
|
1.11 mm | 98.61 k shares | 0.50 | Common equity | Long | Cayman Islands |
State Street Institutional Liquid Reserves Fund | 178.86 k | 178.79 k shares | 0.08 | Short-term investment vehicle | Long | USA |
SAVA Cassava Sciences Inc | 0 | 73.70 k shares | 0.00 | Equity derivative | N/A | USA |